Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant
NCT03966209
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Liver Transplantation
Interventions
DRUG:
JS001(PD-1 inhibitor)
Sponsor
Shanghai Zhongshan Hospital